PT - JOURNAL ARTICLE AU - CHRISTINE V. SAPAN AU - ROGER L. LUNDBLAD TI - Considerations Regarding the Use of Blood Samples in the Proteomic Identification of Biomarkers for Cancer Diagnosis DP - 2006 May 01 TA - Cancer Genomics - Proteomics PG - 227--230 VI - 3 IP - 3-4 4099 - http://cgp.iiarjournals.org/content/3/3-4/227.short 4100 - http://cgp.iiarjournals.org/content/3/3-4/227.full SO - Cancer Genomics Proteomics2006 May 01; 3 AB - Blood is the most common source of biomarkers for use in the diagnosis and prognosis of malignant disease. Utilizing proteomic technology for biomarker identification offers greatly increased sensitivity. Such an increase in sensitivity requires precise sample preparation to eliminate any bias in analysis. Here, issues concerning the use of blood, plasma and serum for proteomic analysis are summarized.